The NHS has been accused by leading health charities of attempting to
“severely limit” the introduction of new drugs to treat hepatitis C
because they are too expensive – despite the cost of them being cleared
by officials.
The organisations have called on the Health Secretary to intervene,
saying that NHS England has made a series of “unprecedented requests”
for patients’ access to new drugs to be delayed because of the price.
Yet Nice has approved the drugs as “cost-effective”, leading to a plea
from 14 organisations and senior doctors including the Hepatitis C
Trust, the National Aids Trust and The Haemophilia Society to Jeremy
Hunt.
Read more...Labels: access to drugs, cost of drugs, NHS, UK